Clinical Trials Directory

Trials / Completed

CompletedNCT05636189

Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature.

Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature in Patients Undergoing Urologic Surgery.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Inje University · Academic / Other
Sex
All
Age
20 Years – 90 Years
Healthy volunteers
Accepted

Summary

Hypothermia occurs frequently during general anesthesia. This study is to evaluate the efficacy of 10 minutes of prewarming during induction of general anesthesia during urologic surgery.

Detailed description

Hypothermia is of continuous issue in patients undergoing general anesthesia. During urologic operation (transurethral resection of bladder and prostate), bladder irrigation worsens hypothermia. Hence, various methods including prewarming of the patient are used to maintain core temperature during operation. Prewarming is found to be effective in maintaining core temperature perioperatively by increasing peripheral tissue heat content. However, applying more than 30 minutes of prewarming may be impractical as a clinical routine practice. Hence, developing simple and effective method to prevent hypothermia is expected. Here, the investigators planned to examine the effect of active warming (10 minutes of warming during induction of general anesthesia and prewarmed intravenous fluid intraoperatively) on hypothermia in patients undergoing urologic operation under general anesthesia.

Conditions

Interventions

TypeNameDescription
PROCEDUREwarming during induction of anesthesiaWarming group patients are applied air-forced warming device (bair-hugger 43'C) with blanket (warm touch, COVIDIEN, full body blanket) during induction of anesthesia in the operation room.
PROCEDUREPrewarmed intravenous fluid administrationPrewarmed intravenous fluid is connected.

Timeline

Start date
2022-11-01
Primary completion
2023-08-08
Completion
2023-08-08
First posted
2022-12-05
Last updated
2023-08-30

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05636189. Inclusion in this directory is not an endorsement.